Does BOTULINUM TOXIN TYPE A Cause Musculoskeletal stiffness? 331 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 331 reports of Musculoskeletal stiffness have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 8.9% of all adverse event reports for BOTULINUM TOXIN TYPE A.
331
Reports of Musculoskeletal stiffness with BOTULINUM TOXIN TYPE A
8.9%
of all BOTULINUM TOXIN TYPE A reports
318
Deaths
320
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From BOTULINUM TOXIN TYPE A?
Of the 331 reports, 318 (96.1%) resulted in death, 320 (96.7%) required hospitalization, and 317 (95.8%) were considered life-threatening.
Is Musculoskeletal stiffness Listed in the Official Label?
Yes, Musculoskeletal stiffness is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOFACITINIB (7,354)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Musculoskeletal stiffness Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE